Medical Disclaimer

Medical Disclaimer

Last updated: August 2, 2026

Please read this disclaimer carefully before using SemaglutideEdge.com.

For informational purposes only

The content published on SemaglutideEdge.com is intended for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Nothing on this website should be construed as medical advice. All content is provided for general informational purposes only.

Always consult your doctor

Always seek the advice of your physician, pharmacist, or other qualified healthcare provider with any questions you may have regarding a medical condition, medication, or treatment plan — including Ozempic, Wegovy, Mounjaro, Zepbound, or any other GLP-1 receptor agonist or semaglutide-based medication.

Never disregard professional medical advice or delay seeking it because of something you have read on SemaglutideEdge.com.

No doctor-patient relationship

Reading content on SemaglutideEdge.com does not create a doctor-patient relationship between you and SemaglutideEdge or any of its contributors, authors, or editors.

Individual results vary

Weight loss results, side effect experiences, and medication responses vary significantly between individuals. Any content describing typical experiences, timelines, or results does not guarantee the same outcome for any individual reader. Factors including medical history, current medications, lifestyle, and genetics affect how any person responds to GLP-1 medications.

No pharmaceutical affiliation

SemaglutideEdge.com is an independent editorial website. We are not affiliated with, endorsed by, sponsored by, or connected to:

  • Novo Nordisk A/S — manufacturer of Ozempic® and Wegovy®
  • Eli Lilly and Company — manufacturer of Mounjaro® and Zepbound®
  • Any other pharmaceutical company, compounding pharmacy, or telehealth provider

Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective owners. Use of these names on SemaglutideEdge.com is purely descriptive and editorial.

External links

SemaglutideEdge.com may contain links to third-party websites including telehealth providers, supplement companies, pharmacies, and health information sources. We are not responsible for the accuracy, safety, completeness, or content of any external website. Inclusion of a link does not constitute endorsement.

Drug shortage and regulatory information

Information about FDA drug shortage designations, compounding pharmacy regulations, and telehealth prescribing rules changes frequently. While we update our content regularly, always verify current regulatory status with the FDA directly at fda.gov before making any medication decisions.

Emergency situations

If you are experiencing a medical emergency, call 911 or your local emergency number immediately. Do not rely on any website for emergency medical guidance.

Limitation of liability

SemaglutideEdge.com, its owners, authors, and contributors accept no liability for any loss, injury, or damage arising from the use of or reliance on any content published on this website.

Questions about this disclaimer? Contact us here.

© 2025 newsus. All Rights Reserved by BlazeThemes.